The microenvironmental pH and oxygenation is known to influence tumor cell response to heat, radiation, photodynamic and even chemotherapy. We have studied the previously untested influence of acidity and hypoxia on tumor and endothelial cell sensitivity to freezing.
Introduction
The treatment of cancer by applying thermal therapy (hyperthermia or cryotherapy) has a history of over one hundred years, and likely as far back as ancient times (1, 2) . In the last several decades there has been formal scientific study of hyperthermia and cryotherapy and also a number of clinical trials, most of which involved hyperthermia. While the initial trials with hyperthermia were generally not successful due to inefficient heat delivery, recent carefully controlled trials with improved technology have shown significant increases in local control and survival of patients receiving hyperthermia and radiation (3) (4) (5) . The vasculature has been found to play a cardinal role in the response of tissues to both heating and freezing and therefore we hypothesized that many processes in the response of cells and tissues to cold or heat would be similar. We have previously studied the cellular and physiological response to heat by normal and malignant tissues extensively (6) (7) (8) (9) . In the present study the goal was to understand the role of microenvironment in cryo-induced cell death and physiological factors associated with the response of tumor tissue to freezing.
Understanding how the microenvironment controls cellular survival and the response of surviving tissue to cryo-induced tumor destruction may improve cryotherapy applications on living systems and may uncover effective adjuvant treatment strategies. Two well-known factors in the sensitivity of cells and tissues to heat are the pH and oxygenation in the interstitial space as well as the intracellular space (10-13). Tumor cells maintain intracellular pH higher that extracellular pH by active hydrogen exchange. However, the pre-existing extracellular acidity in tumors, such as measured in the FSaII fibrosarcoma used in the present study (14-16), allows intracellular pH (pHi) to be selectively lowered by agents that disrupt membrane exchange of hydrogen ions. It is already well established that lowering the pH inside tumor cells can sensitize them to heat (17, 18) . In addition, a low partial pressure of oxygen (pO 2 ) increases resistance to radiation. Therefore, heating or freezing may destroy radioresistant cells. In general, very little has been done to understand the role of pH or oxygenation on cryosensitivity of cells and tissues and very few comparisons to hyperthermia have been made. We have recently begun to study the role of heat shock proteins and thermotolerance in cryosensitivity of tumor cells (19). Our hypothesis was that thermotolerance induced by heat may also confer tolerance to freezing. Cryo-tolerance was not achieved, however, reducing the intracellular pH of thermotolerant cells appeared to sensitize the cells to subsequent freezing.
The standard use of hyperthermia is as an adjuvant to radiotherapy. The effect that cryotherapy has on radiation response has been looked at in only a few isolated studies including one study that observed a clinical benefit (20) and one study that assessed the effect of hypothermia on DNA damage repair (21). Typically, cryotherapy and radiotherapy are used as primary or salvage therapy and not actually as a combination treatment in prostate cancer patients (22) (23) (24) . In a series of previous studies, a strong link was established between tumor oxygenation after hyperthermia and subsequent radiosensitivity (25) (26) (27) (28) (29) . Here, the tumor oxygenation patterns in the hours and days after cryotherapy of murine FSaII tumors have been assessed. Overall, the current study demonstrates that i) pH and oxygenation play an important role in how cancer cells and the endothelium respond to freeze-injury; and, ii) the tumor and surrounding normal tissue undergo marked changes in oxygenation after freezing, which may allow other therapies to be more successful in destroying malignant tissue.
Materials and Methods

Tumor Model and Cell Lines
FSaII murine fibrosarcomas were grown subcutaneously in the right rear leg of female C3H mice. Briefly, cells growing exponentially in RPMI medium with 10% Bovine calf serum were harvested and about 2 x 10 5 cells were injected to the host animal. The tumors grow to about 1 cm in diameter in 1-2 weeks. Mouse smooth muscle microvascular heart endothelial cells SMHEC (a kind gift of Dr. S. Ramakrishnan, Dept. of Pharmacology at the University of Minnesota -originally from R. Auerbach at University of Wisconsin (30)) were cultured in DMEM with 10% FBS supplemented with antibiotics in standard tissue culture flasks.
Clonogenic Assay
Cells were plated at various densities in glass or plastic flasks. The next day, the cells were treated as described below and immediately returned to a 37º C, 5% CO 2 incubator and cultured for 1 or more weeks to allow surviving cells to form colonies. After visible colonies appeared red the flasks were rinsed with saline, colonies fixed to the flask with 10:1 methanol acetic acid, and stained with crystal violet for counting. Surviving fractions were calculated from the number of colonies vs. number of cells plated, adjusted for plating efficiency for each cell type. Data sets were compared using a two-sample Student's t-test, unequal variance with p ≤ 0.05 considered a significant difference between the means.
Control of pH and pO 2
To adjust the pH alone, we used a hypodermic syringe connected to a gas tank to inject either 2 ml or 25 ml CO 2 gas into 50 ml plastic tissue culture flasks containing known numbers of cells followed by immediately tight closure of the plug-style caps. The flasks contained 3 ml of culture media, and after several minutes the media stabilized at pH 7.5 or 6.6 in response to 2 ml or 25 ml CO 2 , respectively. For pH and pO 2 control glass flasks containing the cells were fitted with an airtight septum and were then flushed with a mix of nitrogen, 0.5% O 2 , and either 5% or 30% CO 2 , creating a pH of 7.5 or 6.6, respectively after several minutes of gas flow. The CO 2 and other gasses were applied for 30 min at which time the sealed flasks were brought directly to the controlled rate freezer for application of cryotherapy.
Freezing Protocols
In Vitro: The viability of FSaII or SMHEC cells was tested by quantification of colony forming ability after treatment. The pH and pO 2 was adjusted as described above. The flasks were then subjected to cryotherapy using a controlled rate freezing (CRF) apparatus at a freezing rate of 5º C/min and an end temperature of -40º C for up to 15 min (31). In preliminary studies, -40º C was found to be an optimal temperature for inducing significant, but not complete cell kill.
In vivo: FSaII tumors (averaging 8 mm × 10 mm in diameter) of anesthetized mice were treated with cryotherapy for 5 min using an experimental -140º C argon-cooled cryoprobe (Endocare, Irvine, CA). These tumors, especially those over 300 mm 3 , are known to contain many regions of acidity compared to adjacent normal tissue (15). The animals were placed on a plexiglass board on top of a digital balance and the tumorbearing legs were gently extended and the foot taped to the board. The probe was 3 mm in diameter and was placed on the top, outside surface of the tumor using a micromanipulator. A balance was used to ensure consistent pressure (3 g) of the probe on the skin overlying the tumor and freezing was commenced with a probe tip temperature of -140º C for 5 min. Control mice were sham treated with a non-cooled probe. The temperature profiles of this freezing, as measured with implanted thermocouples, are shown in Figure 2 . Other work with this therapy system has demonstrated reproducible freeze injury in experimental tissue models (32-34).
Tumor Growth Delay
After cryotherapy, the tumor size was measured using a metric scale caliper every 3-4 days and the tumor volume estimated using the formula a 2 b/2, where a and b are the shorter and longer diameters of the tumor, respectively.
Measurement of Tumor Oxygenation
The pO 2 at 1 and 3 days after tumor freezing was measured with an Eppendorf pO 2 Histograph (Eppendorf, Hamburg, Germany). A pO 2 electrode (300 µm diameter, Eppendorf, Hamburg, Germany) was advanced by a computer-controlled system measuring pO 2 along 5 tracks through the tumor. Normally, 50-60 measurements are recorded per tumor. For the acute measurement of pO 2 at the edge of the iceball, an Oxylab (Oxford optronic, Oxford, UK) fiberoptic pO 2 probe with incorporated thermocouple (35-37) was inserted to several mm and when the temperature reached 0º C at the probe tip the argon was turned off and pO 2 values traced at a single point in realtime. Oxygenation data was analyzed using the non-parametric Mann-Whitney U-test with p ≤ 0.05 considered a significant difference between the mean median values of two groups. Figure 1 is a plot of tumor cell (A) and endothelial cell (B) cryosensitivity in vitro while in either pH 7.5 or pH 6.6 culture conditions with and without hypoxia induction after -40º C for 10 min (FSaII cells) or for 5, 10 and 15 min (SMHEC). As is demonstrated, for FSaII tumor cells there was a significant reduction in cell survival when the pH was lowered to 6.6 for 30 min before and during cryotherapy at -40º C. The induction of hypoxia also caused a sensitization to cryo, however, the combination of low pH and hypoxia did not further sensitize the cells to subsequent freezing. Hypoxia alone had significantly lower survival than cells frozen in an aerobic, neutral environment (p< 0.05), while hypoxia combined with acidity resulted in a slight increase in survival compared to cells in a hypoxic and neutral environment (p=0.07). All cell survival was normalized to survival of cells treated with the corresponding low pH and/or hypoxia alone. The SMHEC mouse endothelial cells were also found to have a significantly greater sensitivity to -40º C when in a low pH environment, as measured by clonogenic survival (p<0.05 for 5 or 10 min hold-times, p= 0.09 for 15 min hold-time).
Results
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Technology Figure 2a is a plot of the FSaII tumor growth delay achieved after a standard 5 min, -140º C freezing protocol of the tumor. This protocol induced a tumor growth delay of approximately 4 days when comparing the average time required for tumor volume to reach 3-fold of the starting volume before treatment. Figure 2b is a plot of the thermocouple data obtained at various points in the tumor during freezing. As illustrated, there was a 40-50º C range in temperatures achieved between the probe tip and the distant edges of the tumor. Figure 3 is a summary of the oxygenation measured in FSaII tumors immediately after cryotherapy and up to 3 days post freezing. The tumor pO 2 at the edge of the iceball (as measured in real-time and shown in Fig. 3A ) exhibited a sharp rise in oxygenation within the first hour after treatment, which then subsided. The median pO 2 of the whole tumor was found to be slightly increased at 1 day after freezing (not significant) and by 3 days after freezing the median tumor pO 2 of the whole tumor had returned to the control level ( Fig. 3B ). However, as is shown in Figure 3C , when only the periphery (the first 3 mm of measurement track) of the tumor was measured there was a significant increase in the median oxygenation at both 1 and 3 days after treatment (p< 0.05).
Discussion
This study incorporates cryotherapy into our ongoing investigations of the role of pH and oxygenation on cellular sensitivity to thermal and radiation injury and the tissue physiological response to these treatments [(18, 19, 38, 39) and Fig. 1 ]. Diseases typically treated with cryotherapy, such as human prostate cancer, are known to have a low partial pressure of oxygen (pO 2 ) as well as a low extracellular pH (16, 40) . In regions of low oxygenation the tumor cells derive energy by anaerobic glycolysis which produces lactic acid and lowers the environmental pH. The observation that endothelial cells are sensitized to cryotherapy by low pH (Fig. 1B) suggests that the tumor vasculature, which appears to play a crucial role in determining freeze injury in vivo, may also be sensitized to freezing by a low pH environment. Hypoxia was not induced in the SMHEC cultures. We reasoned that in vivo the lowest amount of hypoxia is likely to occur in the blood stream (and thus adjacent to the endothelial cells) unless blood flow is interrupted. Intermittent blood flow and subsequent hypoxia is thought to occur in tumors, but there is still debate on the degree to which it occurs and how it affects oxygenation. Nonetheless, the current study demonstrates that acute hypoxia sensitizes tumor cells to cryotherapy, which contributes to our understanding of tumor response to freezing alone or combined with a therapeutic strategy that causes rapid tumor hypoxia to develop. In general, radiation and some types of chemotherapy are ineffective at killing hypoxic cells and therefore freezing-induced hypoxic cell death could play an important role in combination treatment strategies.
An element of the current study that garners some discussion is the issue of acute vs. chronic changes in the tumor microenvironment. The pH and oxygenation status was changed for only 30 min prior to beginning the freezing protocols. The mechanism by which a rapid reduction in pH sensitizes cells to freezing may be related to the fact that intracellular acidification is known to affect gene expression and lead to cell death by apoptosis or necrosis (39, 41, 42) . Other work has elucidated the relationship between hypoxia and thermal sensitivity of tumor cells (43, 44) . These studies found that chronic hypoxia can increase heat sensitivity, but short term hypoxia may protect cells against heat-induced cell death. This relationship is also reflected in the current study using cryotherapy, where cells only exposed to low pH were slightly more sensitive to freezing than cells exposed to both low pH and hypoxia. In vivo there is a considerable amount of tumor tissue predicted to exist long-term in regions of depressed pH and/or hypoxia. For example, the FSaII fibrosarcoma used here has been well-documented to contain Thermocouple data obtained in the center of the tumor (approx. 5 mm below cryo-probe on surface, and subcutaneously at each side of the tumor (approx. 45º across the surface from the cryo-probe) during freezing. The data represents the mean of 11 and 10 animals in control and cryotherapy groups, respectively, for tumor growth delay and thermocouple measurements during three separate therapy sessions ±1 SE. significant acidity (14, 15) , which likely contributed to the cryotherapy-induced growth delay obtained. Tumor cells may become 'adapted' to the suboptimal environment and have modified responses to thermal therapy (45). Therefore, treatments that cause acute changes in microenvironment may be most effective in increasing cryosensitivity by overcoming inherent resistance of adapted tumor cells. The diuretic amiloride and its analogs, which inhibit the sodium/hydrogen anti-port in the cell membrane, have been proven to acutely lower the intracellular pH and sensitize tumor cells to heat in vitro and in vivo. In addition, the pH and pO 2 can be acutely reduced using agents that cause vascular shutdown (38, 46) which may increase the sensitivity of cells adapted to a certain level of acidity and/or hypoxia. Future studies in our lab aim to elucidate the potential of agents specifically designed to reduce pH and/or cause vascular shutdown against malignant cells and tissue in combination with cryotherapy.
The tumor environment can help dictate the cellular response to freezing and it can itself be changed by cryotherapy as demonstrated in Figure 3 . Clearly, the oxygenation level within tumor tissue increases substantially in the hours and days after freezing (Fig. 3) , as demonstrated using two different tissue oxygenation measurement systems. This could be a valuable byproduct of freezing tumor tissue as an aerobic environment increases the cytotoxicity of radiotherapy by up to 3-fold and affects the chemosensitivity of tumor cells as well as cytotoxicity of photodynamic therapy (47, 48) . The cause of the elevation in tumor oxygenation may be due to the inflammatory response to the freezing injury or a reduction in the overall oxygen consumption rate by the tumor cells after freezing. Both processes likely occur in the hours and days after freezing as cells begin to die (thereby reducing the overall oxygen demand of the tumor) and the body attempts to repair the damaged tissue via inflammation. Immediately after freezing (as shown in Fig. 3A) , the spike in tissue oxygenation is at least partially due to an increase in tumor blood flow in an attempt to maintain normal limb temperature during and after the freezing.
One might predict that the use of minimally invasive radiofrequency probes for high temperature treatment would cause similar changes in tumor oxygenation. It should be noted, however, that injury from ablative heating or freezing is distinctly different from one another. High temperature heating causes tissue fixation while freezing damage is typically reabsorbed by the body (32, 49) and therefore assuming that the physiological reaction of the treated tissue will be the same should be avoided. A study directly comparing the two types of therapy would be valuable, especially with the increasing amount of effort being put into engineering and development of both cryotherapy and radiofrequencybased minimally invasive probes for thermal therapy.
In conclusion, acute changes in pH and pO 2 can significantly influence cryosensitivity of tumor cells in vitro. In addition, freezing of tumor tissue in vivo causes dynamic changes in tissue oxygenation. This data may contribute to development of effective adjuvant treatments for clinical use of tumor cryotherapy since a major obstacle to cryosurgical techniques currently is the relatively high rate of treatment failure. By increasing our understanding of the factors that
Cryotherapy Improves Tumor Oxygenation and is Enhanced by Low pH and pO 2 249
Technology influence cell sensitivity to freezing and the physiological response to freezing, cryotherapy can be improved and can be intelligently combined with other standards of care.
